Koyfin Home > Directory > Health Care > Akcea Therapeutics Inc > EV / EBITDA (ltm)

Akcea Therapeutics Inc EV / EBITDA (ltm) Chart (AKCA)

Akcea Therapeutics Inc annual/quarterly EV / EBITDA (ltm) from 2020 to 2020. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the last twelve months (LTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
  • Akcea Therapeutics Inc EV / EBITDA (ltm) for the quarter ending May 05, 2020 was 26.20 a -4.04% decrease of -1.06 year over year
  • Akcea Therapeutics Inc EV / EBITDA (ltm) for the last 12 months ending May 05, 2020 was 26.20 a -4.04% decrease of -1.06 year over year
  • Akcea Therapeutics Inc Annual EV / EBITDA (ltm) for 2020 was 26.20 a 3.71% increase of 0.97 from 2019
  • Akcea Therapeutics Inc Annual EV / EBITDA (ltm) for 2020 was 25.23 a 8.47% increase of 2.14 from 2019
  • Akcea Therapeutics Inc Annual EV / EBITDA (ltm) for 2020 was 23.09 a -18.04% decrease of -4.17 from 2019
Other Valuation Metrics:
  • Akcea Therapeutics Inc Market Cap for the quarter ending March 03, 2018 was $1,709m
  • Akcea Therapeutics Inc Price / Book for the quarter ending March 03, 2018 was 9.49
  • Akcea Therapeutics Inc Enterprise Value for the quarter ending March 03, 2018 was $1,449m
View Chart On Koyfin

Quarterly AKCA EV / EBITDA (ltm) Data

05/202026.20
05/202025.23
05/202023.09
04/202027.25
04/202028.96
04/202028.03
04/202029.18
04/202029.28
04/202028.96
04/202027.12

Annual AKCA EV / EBITDA (ltm) Data

202026.20
202025.23
202023.09
202027.25
202028.96
202028.03
202029.18
202029.28
202028.96
202027.12